Expanding Indications for Stem Cell Transplantation

Seminars in Oncology Nursing

Volumn 25, Issue 2, 2009, Pages 105-114

  Schmit Pokorny, Kim ^a  

^a NONE

Author keywords

hematopoietic stem cell transplantation; Indications

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; EVIDENCE BASED PRACTICE; FORECASTING; HEALTH; HEALTH SERVICE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; NURSING; ONCOLOGY NURSING; PATIENT SELECTION; PRACTICE GUIDELINE; REGISTER; TIME; UNITED STATES;

AUTOIMMUNE DISEASES; EVIDENCE-BASED PRACTICE; FORECASTING; HEALTH SERVICES NEEDS AND DEMAND; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ONCOLOGIC NURSING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; TIME FACTORS; UNITED STATES; WORLD HEALTH;

EID: 65349124151     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2009.03.002     Document Type: Article

References (47)

1. Ferrera J., Anasetti C., Stadtmauer E., et al. Blood and marrow transplant clinical trials network state of the science symposium 2007. Biol Blood Marrow Transplant 13 (2007) 1268-1285
2. Schmit-Pokorny K. Blood and marrow transplantation: indications, procedure, process. In: Ezzone S., and Schmit-Pokorny K. (Eds). Blood and Marrow Stem Cell Transplantation: Principles, Practice, and Nursing Insights (2007), Jones and Bartlett Publishers, Sudbury, MA 75-107
3. Niess D., and Duffy K. Basic concepts of transplantation. In: Ezzone S. (Ed). Hematopoietic Stem Cell Transplantation (2004), Oncology Nursing Society, Pittsburgh, PA 13-21
4. Lennard A., and Jackson G. Science, medicine, and the future: stem cell transplantation. BMJ 321 (2000) 433-437
5. National Marrow Donor Program. Available at: www.marrow.org (accessed)
6. Forman S. Planning and management for related and unrelated donor transplantation: day 10 to day 100. Blood Marrow Transplant Rev 17 (2007) 5-7
7. Ljungman P., Urbano-Ispizua A., Cavazzana-Calvo M., et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 37 (2006) 439-449
8. American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma. ASBMT Position Statement. 2003. Available at: www.asbmt.org/policystat/policy.htm (accessed Sept 9, 2008).
9. Hahn T., Wolff S., Czuczman M., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidenced-based review. Biol Blood Marrow Transplant 7 (2001) 308-331
10. American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in adults. ASBMT Position Statement. Biol Blood Marrow Transplant 14 (2008) 135-136
11. Oliansky D., Appelbaum F., Cassileth P., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 14 (2008) 137-180
12. American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in adults. ASBMT Position Statement. Biol Blood Marrow Transplant 12 (2006) 368-369
13. Hahn T., Wall D., Camitta B., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidenced-based review. Biol Blood Marrow Transplant (2006) xx:1-30
14. Pant S., and Copelan E. Hematopoietic stem cell transplantation in multiple myeloma. Biol Blood Marrow Transplant 13 (2007) 877-885
15. Barlogie B., Tricot G., van Rhee F., et al. Long-term outcome results of the first tandem autotransplant trial for multiple myeloma. Br J Haematol 135 (2006) 158-164
16. American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of multiple myeloma. ASBMT Position Statement. 2003. Available at: www.asbmt.org/policystat/policy.htm (accessed Sept 9, 2008).
17. Hahn T., Wingard J., Anderson K., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. Biol Blood Marrow Transplant 9 (2003) 4-37
18. American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children. ASBMT Position Statement. 2007. Biol Blood Marrow Transplant 13 (2007) 500-501
19. Oliansky D., Rizzo J., Aplan P., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 13 (2007) 1-25
20. American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in children. ASBMT Position Statement. Biol Blood Marrow Transplant 206;12:370-371.
21. Hahn T., Wall D., Camitta B., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidenced-based review. Biol Blood Marrow Transplant (2005) xx:823-861
22. Wingard J. Myelodysplastic syndromes: rejuvenating the senescent. Blood Marrow Transplant Rev 17 (2007) 1
23. Deeg H. Optimization of transplantation regimens for patients with myelodysplastic syndromes. Blood Marrow Transplant Rev 17 (2007) 7-9
24. Scott B. Maximizing treatment outcomes for MDS in the transplantation patient. Blood Marrow Transplant Rev 18 (2008) 5-7
25. Sorror M., Maris M., Sandmaier B., et al. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol 23 (2005) 3819-3829
26. Baccarani M., Saglio G., Goldman J., et al. Evolving concepts in the management of chronic myeloid leukemia: recommendation from an expert panel on behalf of the European LeukemiaNet. Blood 108 (2006) 1809-1820
27. Jabbour E., Cortes J., Kantarjian H., et al. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after bcr-Abl kinase mutation-related imatinib failure. Blood 108 (2006) 1421-1423
28. Gratwohl A., Baldomero H., Demirer T., et al. Hematopoietic stem cell transplantation for solid tumors in Europe. Ann Oncol 15 (2004) 653-660
29. Frenette P., and Atweh G. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 117 (2007) 850-858
30. Bhatia M., and Walters M. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 41 (2008) 109-117
31. Walters M., Patience M., Leisenring W., et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 335 (1996) 369-376
32. Haller M., Viener H., Wasserfal C., et al. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 36 (2008) 710-715
33. Rabusin M., Andolina M., and Maximova N. Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives. Bone Marrow Transplant 41 (2008) S96-S99
34. Marmont A. Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence. Bone Marrow Transplant 38 (2006) 1-4
35. Leung Y., Geddes M., Storek J., et al. Hematopoietic cell transplantation for Crohn's disease; is it time?. World J Gastroenterol 12 (2006) 6665-6673
36. Burt R. New indications in stem cell sources for transplantation for autoimmune diseases. Blood Marrow Transplant Rev 14 (2004) 5-7
37. Pavletic S., O'Dell J., Pirruccello S., et al. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: The University of Nebraska experience. J Rheumatol 28 suppl 64 (2001) 13-20
38. Saccardi R., Mancardi G., Solari A., et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 105 (2005) 2601-2607
39. Le Blanc K., and Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 321-334
40. Friedman R., Betancur M., Boissel L., et al. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 13 (2007) 1477-1486
41. Lazarus H., Koc O., Devine S., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
42. Wirthlin L., Hess D., Zhou P., et al. Human stem cells for tissue repair. Biol Blood Marrow Transplant 14 (2008) 151-153
43. Sharp J., Murphy B., Jackson J., et al. Promises and pitfalls of stem cell therapy for promotion of bone healing. Clin Orthop Relat Res 435 (2005) 52-61
44. Bartley J., and Carroll J. Stem cell therapy for cerebral palsy. Expert Opin Biol Ther 3 (2003) 541-549
45. Burt R., Loh Y., Pearce W., et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299 (2008) 925-936
46. Leung N., Griffin M., Dispenzieri A., et al. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant 5 (2005) 1660-1670
47. Gillmore J., Goodman H., Lachmann H., et al. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 107 (2006) 1227-1229